- Company
-
- Aifinyo AG
- Aixtron SE
- Berentzen Gruppe AG
- Amadeus Fire AG
- Brain Biotech AG
- Carl Zeiss Meditec AG
- Cherry SE
- Deutz AG
- Edag Engineering Group AG
- ElringKlinger AG
- Encavis AG
- Energiekontor AG
- Gerresheimer AG
- Hypoport SE
- Jost Werke SE
- Knaus Tabbert AG
- LEG Immobilien SE
- Mister Spex SE
- Mountain Alliance AG
- Mutares SE
- Nemetschek SE
- PSI Software SE
- Rational AG
- RENK Group AG
- Schaltbau Holding AG
- SFC Energy AG
- Sixt SE
- Talanx AG
- USU Software AG
- Varta AG
- voxeljet AG
- Verve Group SE
- Wacker Chemie AG
- Zeal Network SE
- Presentations
- Index
- Blog
- About
Elevator Pitch
seat11a · investor briefing
Amoeba SA Elevator Pitch | Biocontrol, Cosmetics & Commercial Growth
Elevator Pitch
10:33
Loading video…
June 4, 2026
10:33 
Amoeba SA Elevator Pitch: Key Takeaways
Amoéba SA Elevator Pitch Presentation
In this Elevator Pitch on seat11a, Jean-François Doucet, CEO of Amoéba SA, presents the company’s strategy, technology platform and commercial development plans across agriculture and cosmetics.
A Green Technology Company Built on Proprietary Amoeba Cultivation
Amoéba is a French green technology company specializing in natural bio-solutions derived from proprietary amoeba cultivation technology. The company has spent more than a decade developing a unique industrial platform and has built a portfolio of intellectual property, industrial expertise and commercial partnerships designed to support future growth.
Biological Crop Protection and Sustainable Agriculture
The company’s agricultural activities focus on biological crop protection products designed to offer natural alternatives to conventional chemical solutions. Regulatory milestones have already been achieved, including active substance approval in Europe and product authorization in the United States. These achievements provide the foundation for commercial deployment through strategic partnerships with major industry participants.
Strategic Partnerships with Koppert and Syngenta
Amoéba has signed an exclusive distribution agreement with Koppert for selected crop applications and has established a memorandum of understanding with Syngenta focused on future cereal opportunities. These partnerships provide access to large agricultural markets while leveraging established commercial infrastructures.
Natural Cosmetic Ingredients and Well-Ageing Solutions
The company is also developing a natural cosmetic ingredient targeting skin protection, repair and well-ageing applications. Through partnerships in China and international commercialization efforts, management sees cosmetics as an additional long-term growth driver supported by attractive market dynamics and higher-margin opportunities.
Transition from Development to Commercial Execution
Throughout the presentation, management emphasizes that Amoéba is transitioning from a development-stage story toward commercial execution. With technology validation, regulatory approvals, industrial partners and commercial agreements already in place, the company believes it is entering a new phase focused on market adoption and growth.
Chapters
- Who is Amoéba ?
- Our Solutions
- Why Are We Unique?
- How Do We Commercialise?
- What Have We Achieved?
- Our Unique Technology Platform
- Development is Accelerating for an Initial Launch
- Expected in 2027/2028a
Resources
Host
Share
T&C:
This publication is for informational purposes only and should not be considered investment advice. By using this website, you agree to the terms and conditions outlined in the legal pages at www.seat11a.com/legal/
Continuing the Journey: More Presentations
Discover Additional Elevator Pitches
Reviews for Amoeba SA Elevator Pitch | Biocontrol, Cosmetics & Commercial Growth
There are currently no reviews for Amoeba SA Elevator Pitch | Biocontrol, Cosmetics & Commercial Growth
(c) seat11a – Publicly Listed Companies: Elevator Pitch, Deep-Dive, Financial Results, and ESG
Unlock the insights of top publicly listed companies with seat11a.com